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Outcomes of inpatients with severe mental illness:
a naturalistic descriptive study
Gabriela L. Nuernberg, Fernanda L. Baeza, Marcelo P. Fleck, Neusa S. Rocha
Hospital de Clı´nicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Objective: To describe and evaluate the response and predictors of remission during inpatient
treatment in a psychiatric unit in a general hospital based on symptomatology, functionality, and quality
of life (QoL).
Methods: Patients were admitted to a psychiatric unit in a tertiary general hospital in Brazil from June
2011 to December 2013 and included in the study if they met two of the severe mental illness (SMI)
criteria: Global Assessment of Functioning (GAF) p 50 and duration of service contact X 2 years.
Patients were assessed by the Brief Psychiatric Rating Scale (BPRS), the Clinical Global Impression
(CGI) Severity Scale , GAF, the World Health Organization Quality of Life Instrument – Abbreviated
version (WHOQOL-Bref), and specific diagnostic scales.
Results: A total of 239 patients were included. BPRS mean scores were 25.54611.37 at admission
and 10.9668.11 at discharge (p o 0.001). Patients with manic episodes (odds ratio: 4.03; 95%
confidence interval: 1.14-14.30; p = 0.03) were more likely to achieve remission (CGI p 2 at
discharge) than those with depressive episodes. Mean length of stay was 28.95619.86 days. All QoL
domains improved significantly in the whole sample.
Conclusion: SMI patients had marked improvements in symptomatic and functional measures during
psychiatric hospitalization. Patients with manic episodes had higher chance of remission according to
the CGI.
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Introduction
One of the definitions of severe mental illness (SMI) is based
on two major National Institute of Mental Health (NIMH)
criteria1: 1) duration, characterized as ‘‘prolonged illness’’
and ‘‘long-term treatment’’ with a history of mental illness or
treatment equal to or greater than 2 years; and 2) disability,
which includes dangerous or disturbing social behavior,
moderate impairment of work and non-work activities, and
mild impairment in the performance of activities of daily living
and in the fulfillment of basic needs.2,3 SMI accounts for
significant functional impairment, higher public health spend-
ing, and poorer quality of life (QoL). Population studies
suggest that SMI patients die earlier, specifically from injuries
and suicide.4 SMI is a risk factor for chronic disorders, such
as smoking, low physical activity levels, poor diet, and
accidental and non-accidental injuries.5
Psychiatric hospitalization has been offered as a thera-
peutic strategy for acute cases and remains a key
component of mental health care.6 Acute psychiatric inpa-
tient treatment represents the most intensive level of
psychiatric care, whose goal is the stabilization of highly
acute and severe psychiatric conditions associated with
danger to self or others and/or marked functional impair-
ment. Usually, acute inpatient treatment within an inte-
grated community-based health system consists mainly of
crisis stabilization and safety.7 Consequently, it focuses on
rapid discharge and, within a ‘‘balanced care model,’’
patients are usually admitted to acute wards in general
hospitals,8 which helps minimize the associated stigma
and allows easier access to exams.9
The number of psychiatric beds has decreased in many
countries, such as the United States7 and Brazil,10 in recent
decades. In the 1970s, there were approximately 500,000
psychiatric beds in the United States, 80% of which were in
psychiatric institutions (hospitals). The total number of psy-
chiatric beds decreased by about 50% up to 2002.7 Before
the 21st century, psychiatric care in Brazil was mainly based
on a centralized model with large psychiatric hospitals, longer
length of stay, and poor community care, provided mostly by
outpatient clinics, with exiguous psychiatric care in general
hospitals. Changes in Brazilian healthcare policies led to the
implementation of deinstitutionalization programs, financing
of new community centers (such as Psychosocial Community
Centers [CAPS], which provide day hospital care for severe
mental disorders11), cuts in hospital care expenses, and use
of high-priced medications in outpatient care.12 However,
there is still a shortage of psychiatric beds in the Brazilian
public health sector.10
Previous naturalistic studies reported outcomes during
psychiatric inpatient care. A previous study in Brazil
revealed that age and employment status were significant
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predictors of inpatients’ treatment non-response in a
general hospital unit while 80% of the sample benefited
from hospitalization, despite the lack of standard evalua-
tions.13 In a study of schizophrenic inpatients, Spellmann
et al.14 showed statistically significant improvements from
admission to discharge using Global Assessment of
Functioning (GAF) and the Social and Occupational Func-
tioning Assessment Scale to assess functional status and
the Positive and Negative Syndrome Scale (PANSS) to
evaluate symptoms. Their study demonstrated that unem-
ployed patients had a significantly worse functional out-
come at discharge and that the lower number of previous
hospitalizations and PANSS negative symptom scores at
admission had a better prognosis in terms of functional
outcome after 1 year. By using the Hamilton Depression
Rating Scale (HAM-D), the Montgomery-A˚sberg Rating
Scale, the Clinical Global Impression (CGI) scale, GAF,
and Lancashire QoL Profile, Seemu¨ller et al.15 reported a
68.9% response rate with 51.9% remission in depressed
inpatients. The Munich Antidepressant Response Signa-
ture (MARS) project16 evaluated the outcomes of inpa-
tients clinically diagnosed with depression using 21 HAM-D
items, the Hamilton Anxiety Rating Scale (HAM-A), and the
revised version of the self-rating Symptom Checklist-90. Most
patients benefited from antidepressant treatment during hos-
pitalization (80.8% responded and 57.9% achieved remission
in HAM-D) and early partial response was a positive predictor
of remission. Treatment resistance and the presence of a
migration background were negative predictors.16 The
European Mania in Bipolar Longitudinal Evaluation of Medi-
cation Study17 included both inpatients and outpatients in its
sample, assessing overall CGI-Bipolar Disorder (CGI-BP),
CGI-BP mania, CGI-BP depression, and CGI hallucinations/
delusions, the Young Mania Rating Scale (YMRS), the five-
item version of the HAM-D, and the functional outcomes
of patients with a manic/mixed episode. At the 12-week
endpoint, YMRS response rates were 89.1 and 83.2% for
the first-episode and multiple-episode groups, respec-
tively.17 Even though the mentioned studies indicated
improvement in all measures evaluated during hospitali-
zation, they did not include broad outcome evaluations
such as QoL, symptoms, and functional status. Moreover,
those studies did not use SMI criteria for the selection of their
sample, which probably resulted in a sample with less severe
cases.
Although widely used, few data are currently available on
the characteristics and on the effect of treatment of acute
inpatients in tertiary general hospitals in low- and middle-
income countries. There are also scientific and clinical gaps
between the results of randomized controlled trials and
the care actually received by psychiatric patients.15 Anyway,
quality monitoring is a feasible recommendation even in
settings with limited resources.8
The objective of this study was to evaluate and describe
the general response of SMI patients to treatment during
acute psychiatric hospitalization in a low- and middle-
income country (Brazil) in terms of symptoms, functionality,
and QoL. The secondary objectives were to evaluate
clinical and sociodemographic predictors of clinical remis-
sion and to describe the characteristics of the sample and
of inpatient treatment.
Methods
This study was developed in the tertiary psychiatric care
unit of Hospital de Clı´nicas de Porto Alegre (HCPA), a
teaching hospital affiliated with Universidade Federal do
Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. The
inpatients received individualized treatment in an interdisci-
plinary setting, including psychopharmacological manage-
ment, electroconvulsive therapy (ECT), and psychotherapeutic
interventions involving individual and/or family therapy, occu-
pational therapy, aerobic exercise, and nursing care.
A naturalistic study design, in which the research team did
not interfere with the choice or provision of treatment, was
used. All patients aged 18 years or older and admitted
between June 2011 and December 2013 were invited to
participate. Patients were included if they met two of the
SMI criteria: GAFp 50 (in the initial evaluation) and dura-
tion of previous service contact X 2 years.2,3 The follow-
ing exclusion criteria were used: insufficient communication
skills to participate in the interview or to provide a written
informed consent, primary diagnosis of drug or alcohol
dependence (the inpatient unit does not treat patients with
drug or alcohol dependence), and hospitalization for less
than 7 days (due to limitations of the research team). The
study was conducted in compliance with the Declaration of
Helsinki and was approved by the local ethics committee
(protocol GPPG-HCPA 100265).
Upon admission to the inpatient unit, consecutive patients
were screened for eligibility. Within 72 hours of hospitaliza-
tion, clinical evaluations by the Mini-International Neuropsy-
chiatric Interview (MINI)18 and by the Cumulative Illness
Rating Scale (CIRS)19 to evaluate comorbidities, in addi-
tion to sociodemographic assessments, were performed by
trained psychiatrists and psychiatry residents. Self-rated
measures were used to study a range of clinical, social, and
functional outcomes associated with treatment throughout
the observation period. The following parameters were also
assessed at admission and within 72 hours of discharge:
CGI,20 a clinician-rated seven-point scale that measures
disease severity; the Brief Psychiatric Rating Scale
(BPRS),21 to measure psychiatric symptoms such as de-
pression, anxiety, hallucinations, and unusual behavior;
GAF,22 to measure symptomatology and functioning; the
World Health Organization Quality of Life Instrument –
Abbreviated version (WHOQOL-Bref),23 the 26-item
WHO instrument, to measure QoL related to health and
health care; HAM-D,24 a 17-item scale that measures
depressive symptomatology; YMRS,25 an 11-item multiple-
choice questionnaire that assesses the severity of mania;
and HAM-A,26 to measure the severity of anxiety symptoms.
The latter three assessments were only performed if the
patient presented with depressive episodes, manic episode,
and generalized anxiety disorder, according to the MINI.
SPSS version 18.0 was used for the statistical analyses.
A significance level of po 0.05 was used for all comparisons.
Demographic and clinical data were described, and treatment
outcome variables were compared using a Student’s t test for
independent and paired samples (parametric data). The
scores obtained at admission were compared to the scores
at discharge in the total sample and among the different listed
diagnostic subgroups. A logistic regression analysis was
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applied to evaluate the effects of potential predictor and
confounding variables on response at discharge. Gender,
age, partnership status (single, widowed, or divorced),
occupational status (unemployed or invalidity allowance),
CGI scores at admission, age at disease onset, number of
previous hospitalizations, comorbidity with anxiety, diagno-
sis of depressive episode, manic episode, or schizophrenia,
length of stay (LOS), and treatment (antidepressant, mood
stabilizer, antipsychotics other than clozapine, clozapine, or
ECT) were assessed. Variables with a p value p 0.2 in
the univariate analysis were included in the regression
analysis. CGI scores p 2 at discharge were defined as a
remission criterion.27
Results
Sample characteristics
A total of 239 SMI patients were included in the study
(Figure 1). The baseline characteristics of the sampled
patients are listed in Table 1. Almost 65% of the patients
had attempted suicide at least once and almost 76% had
been previously referred for psychiatric hospitalization.
During our study, there were eight non-fatal suicide attempts
and one successful suicide. Mean LOS was 28.95619.86
days. According to the MINI, the most frequent diagnoses
were depressive episodes (63.2%), followed by psychosis
(20.9%), which includes schizophrenia and related disor-
ders, and manic episodes (15.9%); there was high comor-
bidity with anxiety disorders (65.5%). The treatments and
their frequencies are listed in Table 2.
The CIRS revealed that the frequency of at least one
comorbid disorder (other than psychiatric) was 74.5%.
The mean CIRS score (excluding psychiatric conditions)
was 2.3562.49, and the most frequent comorbid dis-
orders were hypertension (17.9%), diabetes (12.1%),
hypothyroidism (8.1%), rhinitis (3.1%), epilepsy (3.5%),
and human immunodeficiency virus (HIV) infection/
acquired immunodeficiency syndrome (AIDS) (2.6%).
Symptomatic, functional, and QoL outcomes
BPRS, CGI, and GAF
BPRS scores significantly improved during hospitalization,
yielding means of 25.54611.37 at admission and 10.9668.11
at discharge (p o 0.001). An overall CGI mean score of
4.8761.17 at baseline indicated moderate illness severity.
These mean scores improved to 3.761.32 at discharge (po
0.001), indicating mild severity. Patients also experienced
significant mean improvements in functionality (GAF) from
baseline to endpoint. GAF mean levels were 33.26613.75
Figure 1 SMI patients included in the study. LOS = length of stay; SMI = severe mental illness. * Clinical and psychiatric
conditions that prevented informed consent from being obtained. w Excluded a posteriori due to limitations of the research team.
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at admission and 64.41613.80 at discharge (p o 0.001).
The results of these variables for each diagnostic subgroup
are shown in Table 3.
WHOQOL-Bref
The WHOQOL-Bref was assessed in 171 patients upon
admission and at discharge. All QoL domains improved
significantly when the total patient sample and the
depressive episode subgroup were considered. However,
in the manic episode subgroup, only the psychological
and social domains showed significant improvement, as
also did the psychological and physical health domains in
the psychosis subgroup (Table 4).
Specific symptomatic scales
HAM-D
Among patients with depression, the mean HAM-D scores
improved from 23.4066.88 at admission to 7.0664.74 (po
0.001) at discharge. At discharge, the response rate (X 50%
decrease from the baseline total HAM-D score) was 82% and
the remission rate (HAM-D p 7) was 52%.
YMRS
In patients with manic/mixed episodes, the mean YMRS
scores were 23.7169.88 at admission and 4.6263.70 at
discharge (po 0.001). The response rate (X 50% decrease
from the baseline total YMRS score) was 84% and the
remission rate (YMRS p 7) was 81%.
HAM-A
Patients diagnosed with generalized anxiety disorder by MINI
were further assessed using the HAM-A. A total of 67 patients
were assessed; the mean scores were 30.2869.85 at admis-
sion and 10.5568.91 at discharge. A total HAM-A score
response (X 50% reduction in total HAM-A score) was veri-
fied in 80% of the patients whereas remission (HAM-Ap 7)
was verified in 48% of the patients.
Remission (CGI)
In the analyzed sample, 47 (15.6%) patients achieved remis-
sion during their hospital stay (CGI p 2 upon discharge).
After the univariate analysis, diagnosis (depressive episode,
manic episode or schizophrenia) was included in the reg-
ression model as a possible predictor of remission, adjusted
by CGI scores at admission. The estimates of the effects of
the predictor variables calculated from the regression are
summarized in Table 5. There was no evidence of multi-
collinearity. Patients with manic episodes (odds ratio = 4.03;
95% confidence interval [95%CI] 1.14-14.30; p = 0.03) were
more likely to achieve remission in CGI scores when com-
pared with patients with depressive episodes.
Discussion
Overall, the present study demonstrated that the intensity
of SMI symptoms markedly decreased and that patients
improved their function and QoL during the hospital stay.
Moreover, patients with manic episodes, when compared
with those with depressive episodes, were more likely to
achieve CGI remission. To our knowledge, few studies
performed in a general hospital setting in Brazil have
assessed improvement of symptoms, functions, and QoL
among acute SMI patients during hospitalization.
Despite debates on and policies against the use of
inpatient therapy, this type of treatment modality in general
hospitals, in addition to non-hospital integrated community
care, is still a strong necessity.8 In Brazil, public mental health
care focuses on CAPS, which should be the main referral
centers for severe cases, thus avoiding ward admissions
(psychiatric hospitals or psychiatric wards in general hos-
pitals) whenever possible.11 SMI patients usually require
different levels of care depending on the intensity of
symptoms, and available evidence supports the combina-
tion of community services and modern hospital care.28
However, there has been a shortage of psychiatric beds
in general hospitals in Brazil in recent years.11
Table 1 Sociodemographic and clinical characteristics of
sampled patients
Variable n=239
Gender (female) 133 (55.9)
Age (years) 46.42614.59
Race (white) 123 (87.9)
Weight (kg) 75.55618.28
Grade repetition 96 (44.7)
Education (years) 9.2164.65
Employment status
Employed 62 (27.2)
Unemployed 46 (20.2)
Homemaker 10 (4.4)
Student 4 (1.8)
Retired 34 (14.9)
Invalidity allowance 72 (31.5)
Partnership status
Single 85 (37.1)
Married/living with a partner 87 (38)
Separated 41 (17.9)
Widowed 16 (7.0)
Economic status*
A 17 (12.2)
B 51 (36.7)
C 53 (38.1)
D-E 18 (12.9)
GAF (admission) 33.26613.75
Duration of the disorderw (years) 15.11611.87
Previous suicide attempt 141 (64.7)
Previous psychiatric hospitalization 180 (75.9)
Number of previous hospitalizations 4.1165.50
Length of hospitalization (days) 28.31615.59
Smoking status (current smoker) 62 (32.5)
Data presented as n (%) or mean 6 standard deviation.
GAF = Global Assessment of Functioning.
*Brazilian Economic Classification Criteria (‘‘Criterion Brazil’’)
mean monthly household income in U.S. dollars (A: 5,358;
B: 2,915-1,513; C: 905-620; D-E: 434).
wDuration of the disorder = time elapsed since the first medical
diagnosis.
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Many of the positive outcomes shown in the present
study may result from the use of multiple strategies during
inpatient treatment: optimized pharmacological treatment
combined with a multidisciplinary approach, including psy-
chotherapy and sociotherapeutic strategies. Differently
from what we initially thought, the use of clozapine and
ECT was not a good predictor of clinical remission. ECT
was used in approximately 30% of patients with mood
disorders (unipolar and bipolar depression) while clozapine
was given to 40% of psychotic patients. Thus, it is essential
that we not underestimate the benefits of intensive care for
acute episodes, which includes recreational therapy and
Table 2 Pharmacological and non-pharmacological treatment profiles according to diagnosis (MINI)
Psychosis*
(n=50)
Depressive episode
(n=151)
Manic and mixed episode
(n=38)
ECT 12 (24.0) 51 (33.8) 12 (31.6)
Psychotherapy 6 (12.0) 55 (36.4) 12 (31.6)
Antipsychotics
Typical 7 (14.0) 14 (9.3) 6 (15.8)
Atypical 13 (26.0) 70 (46.4) 15 (39.5)
Clozapine 20 (40.0) 10 (6.6) 9 (23.7)
Mood stabilizers
Anticonvulsants 16 (32.0) 23 (15.2) 15 (39.5)
Lithium - 12 (7.9) 15 (39.5)
Antidepressants
SSRIs 5 (10.0) 61 (40.4) 4 (10.5)
SNRIs - 8 (5.3) -
TCAs 2 (4.0) 9 (6.0) -
Other - 17 (11.3) -
Benzodiazepines 13 (26.0) 29 (19.2) 7 (18.4)
Data presented as n (%).
ECT = electroconvulsive therapy; MINI = Mini-International Neuropsychiatric Interview; SNRIs = serotonin and norepinephrine reuptake
inhibitors; SSRIs = selective serotonin reuptake inhibitors; TCAs = tricyclic antidepressants.
*Schizophrenia and other psychotic disorders.
Table 3 Main diagnosis (MINI) at baseline and the respective clinical measures at admission and at discharge
Depressive episode (n=117) Manic/mixed episode (n=19) Psychosis* (n=33)
Admission Discharge p-valuew Admission Discharge p-value Admission Discharge p-value
BPRS 22.3968.85 8.5165.89 o 0.001 29.48611.69 12.7467.68 o 0.001 32.33614.30 17.30610.91 o 0.001
CGI 4.3160.92 3.4361.15 o 0.001 5.9660.84 3.8461.65 o 0.001 5.7960.96 4.4561.27 o 0.001
GAF 33.26613.75 64.41613.80 o 0.001 28.14611.70 53.90618.43 o 0.001 26.11610.81 47.71619.08 o 0.001
HAM-D 24.1466.98 7.8365.32 o 0.001 22.8165.52 8.3866.38 o 0.001 - - -
YMRS - - - 22.74610.28 4.1664.07 o 0.001 - - -
HAM-A 30.2769.99 10.8968.54 o 0.001 30.75610.71 10.00613.11 0.005 - - -
Data presented as mean 6 standard deviation.
BPRS = Brief Psychiatric Rating Scale; CGI = Clinical Global Impression Scale; GAF = Global Assessment of Functioning; HAM-A = Hamilton
Anxiety Rating Scale; HAM-D = Hamilton Depression Rating Scale; MINI = Mini-International Neuropsychiatric Interview; YMRS = Young
Mania Rating Scale.
*Schizophrenia and other psychotic disorders.
wStudent’s t test; all p-values were statistically significant.
Table 4 WHOQOL-Bref assessments at admission and at discharge in the main diagnostic subgroups
Depressive episode (n=117) Manic/mixed episode (n=23) Psychosis* (n=33)
WHOQOL-Bref
domains Admission Discharge p-valuew Admission Discharge p-value Admission Discharge p-value
Physical health 42.97614.44 53.58613.25 o 0.001 54.19624.24 58.85613.66 0.21 50.29621.28 59.31615.50 0.01
Psychological 38.53615.31 51.26616.75 o 0.001 48.44624.17 61.28620.28 0.001 54.86620.99 62.08617.45 0.01
Social
relationships
42.84623.52 56.21623.97 o 0.001 46.01626.58 57.97620.18 0.03 49.35629.90 59.11624.54 0.06
Environmental 48.90617.95 58.72615.94 o 0.001 49.24621.12 56.77614.75 0.11 54.30619.41 58.25613.34 0.18
Data presented as mean 6 standard deviation.
WHOQOL-Bref = World Health Organization Quality of Life Instrument - Abbreviated version.
*Schizophrenia and other psychotic disorders.
wStudent’s t test.
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implementation of appropriate physical exercise, sleep, and
meal-time routines.
QoL assessment results in this study are consistent with
those of previous investigations, which showed that symp-
tom relief in several psychiatric disorders was associated
with significant improvements in QoL. By contrast, Rubio
et al.29 showed that although the remission of several
psychiatric disorders correlated with significant improvement,
remission was generally not associated with full restoration
of health-related QoL, even among those without comorbid-
ities. Consequently, additional investigation is necessary to
compare restoration of QoL with the treatment received by
psychiatric inpatients and by the general population. Evi-
dence suggests that QoL can be regarded as an indepen-
dent outcome criterion unrelated to schizophrenia and
bipolar disorder (especially mania) symptoms given that
the extent of association is too small.30 It is therefore neces-
sary to confirm the validity of self-assessed instruments in
psychotic patients. A literature review of studies on schizo-
phrenic patients concluded that QoL is a valid and useful
outcome criterion.31 Further studies should also estimate the
contribution of depressive and anxious symptoms, as well as
other variables, to the QoL of schizophrenic and manic
patients. Moreover, the results obtained for mood disorders
in the present study were similar to those previously reported
in the literature. Previous studies on the relationship between
QoL and depression have generally shown that QoL deficits
in depressed patients are attributable to mood disorders and
that their treatment is usually associated with improvements
in QoL.32 Further studies are necessary for a more in-depth
investigation of the contribution of clinical and sociodemo-
graphic variables to QoL in this population.
In our study, only one patient committed suicide, while
eight had unsuccessful suicide attempts during their stay.
Since this is a strictly supervised unit with highly well-trained
personnel, those events should be considered indicators of
the severity of mental disorders among inpatients.
Even though hospitalization was a little longer in the pre-
sent study, our mean length of stay is clinically comparable
to studies that apparently provided similar inpatient treatment
in Brazil. Mean LOS in previous studies were 27.1615.0
days33 and 20.3616.6 days.13 Also, mean LOS according
to data on Brazilian public inpatient treatment was 14 days
for psychiatric wards in general hospitals,11 compared to
a median LOS of 15 days (95%CI 14-15) among manic
inpatients treated in private facilities.34 Moreover, in other
countries, Masters et al.35 had a mean LOS of 19.3621.2
days and Thompson et al.36 reported a mean hospital stay of
35.4651.9 days. However, longer LOS is reported in the
literature. Seemu¨ller et al.15 reported a mean inpatient treat-
ment duration of 53.6647.5 days while the MARS project
had an average hospitalization time of 82.6660.2 days.16 We
believe the prevalence of severe and resistant disorders
contributed to the results observed in the present study.
Our results also confirm a high incidence of other
clinical comorbidities in psychiatric patients. For example,
the prevalence of HIV/AIDS was 10 times higher than in
the general Brazilian population.37 Conversely, the pre-
valence of hypertension was almost the same as in the
general population.38 The present results might indicate
these chronic disorders are underdiagnosed, even in our
tertiary care center.
Some limitations of our study should be acknowledged.
First, since it is a naturalistic study of patients with acute
episodes, our results might indicate a ‘‘return-to-the-mean’’
effect. However, the mental severity of our patient sample
argues against this hypothesis. Second, we could not
assure that patients who refused to participate had exactly
the same profile as those who agreed to their inclusion in
this study. Third, the naturalistic study design is associated
with many treatment-related variables that could not be
controlled for. On the other hand, this allows us to ensure
that the treatment provided in our study is ‘‘true-to-life.’’
Lastly, our data show the acute results of an acute inter-
vention. We did not evaluate if the improvements observed
are stable over time, nor what should be done in terms of
maintenance therapy.
SMI patients showed significant improvement of symp-
toms, function, and QoL during their stay in a general
tertiary hospital. It is not possible to conclude whether the
observed outcomes are related to inpatient treatment.
However, psychiatric hospitalization allowed for a more
intensive treatment and for the use of multiple strategies.
Our data suggest that psychiatric inpatients can have
marked acute improvements during relatively short inter-
ventions (of approximately one month).
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Table 5 Logistic regression for prediction of remission* (CGI p 2 upon discharge) during inpatient treatment (n=163)
95%CI for OR
p-value
Independent variablesw B SE OR Lower Upper
Diagnosis, depressive episode - - 1.00 - - -
Diagnosis, schizophrenia -0.40 0.81 0.66 0.13 3.32 0.62
Diagnosis, manic episode 1.01 0.64 4.03 1.14 14.30 0.03=
Constant 0.99 0.93 2.70 - - 0.29
Adjusted for Clinical Global Impression Scale (CGI) scores at admission. R2 = 0.049 (Hosmer & Lemeshow); 0.072 (Cox & Snell); 0.125
(Nagelkerke). w2 of the model: 12.16, p = 0.007.
95%CI = 95% confidence interval; OR = odds ratio; SE = standard error.
*Remission (CGI p 2 upon discharge) is the dependent variable, coded as 0 = no; 1 = yes (reference category).
wDiagnosis: 0 = depressive episode (reference category); 1 = schizophrenia; 2 = manic episode.
= p o 0.05.
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